ABVC vs KLAC · rev $796.0K vs P/E 55, rev $13.58B
ABVC Biopharma Inc (ABVC) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
Latest reported KLAC revenue for 2026-06-30 was $13.58B. Net income was $4.83B. Revenue was up 11.7% from 2025-06-30 to 2026-06-30. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
ABVC currently screens at market cap $35.9M. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the ABVC and KLAC stock pages for the full models.
Not investment advice.